Page 38 of 91
The Yin & Yang of HIV The Yin Yang HIV When put to the test, conventional HIV/AIDS theory is at odds with the clinical evidence. Is "purified HIV" no more than a tangle of cellular debris? Part 3 of 3 Discovery consists of seeing what everybody has seen and thinking what nobody has thought. — Albert Szent-Gyorgyi, Physician and Nobel Laureate THE DIAGNOSIS OF "HIV" INFECTION 2 What proof is there for the existence of HIV? cientific evidence for the existence of a retrovirus must be consistent with the defi- nition of a retrovirus as a particular kind of replicating, microscopic particle. Thus researchers must demonstrate the correct size, shape and construction of particles; that these particles have been purified and analysed and contain RNA as well as an enzyme (reverse transcriptase) that makes DNA from RNA; and that the particles are infectious—that is, when pure particles are introduced into fresh cell cultures, identical progeny appear. The latter necessitates a second round of purification and analysis. Indeed, although this method is entirely logical and was deemed essential at a meeting held at the Pasteur Institute in 1973,” it has been ignored by all HIV researchers. Although there are electron microscope (EM) photographs from unpurified cell cultures of particles purported to be HIV particles, it was not until March 1997 that EMs of "puri- fied HIV" were published.''” Yet such data is the first, most essential step in attempts to prove particles are a virus, and for subsequent extraction of constituents for analysis and use as diagnostic reagents. These long-awaited micrographs reveal "purified HIV" to be a tangle of cellular debris. Scattered amongst this are scant particles which, without evi- dence, the authors claim are the HIV particles and which "copurify" (sic) with the cellular material. Close examination of these particles as well as other evidence in the papers shows they are too large, wrongly shaped, have too high a mass, and are devoid of knobs that HIV experts unanimously assert are absolutely essential for the "HIV" particle to cause infection. It is from this material that HIV/AIDS experts and biotechnology compa- nies obtain proteins and RNA to use in tests to pronounce humans infected with a unique, exogenous, AIDS-causing microbe. On 17 July 1997, the French investigative television journalist Djamel Tahi interviewed Professor Luc Montagnier in camera at the Pasteur Institute in Paris. Montagnier was asked: "Why do the EM photographs published by you [in 1983] come from the culture and not the purification?" His reply was: "There was so little production of virus it was impossible to see what might be in a concentrate of the virus from the gradient ["pure virus"]. There was not enough virus to do that. Of course one looked for it, one looked for it in the tissues at the start; likewise the biopsy. We saw some particles but they did not have the morphology typical of retroviruses" [italics ours].°' Questioned about the Gallo group, Montagnier replied: "Gallo? I don't know if he really purified. I don't believe so." This should have been both the beginning and the end of HIV. Retrovirus-like particles are virtually ubiquitous in biological material,''* including, for example, cell cultures and "the majority if not all human placentas".'** (Note that Montagnier refers to EMs obtained from umbilical-cord blood lymphocytes.) However, as Gallo confirms, the majority of retrovirus-like particles are not retroviruses because they do not replicate.'*''* The "HIV" particle has been "classified" into two subfamilies and three genera of retroviruses. This is analogous to describing a new species of mam- mal as a human, a gorilla and an orang-utan. Besides the "HIV" particle, cell cultures contain other particles of numerous © 1999 by Valendar F. Turner Department of Emergency Medicine Royal Perth Hospital Perth, Western Australia and Andrew Mcintyre Freelance Journalist Melbourne, Victoria, Australia and Andrew Mcintyre Freelance Journalist Melbourne, Victoria, Australia NEXUS - 37 OCTOBER — NOVEMBER 1999